Mixed platelet and coagulation disorders: Pathology review

Last updated: August 27, 2021

Mixed platelet and coagulation disorders: Pathology review

Watch later

Watch later

Escherichia coli
Mycobacterium tuberculosis (Tuberculosis)
Mycoplasma pneumoniae
Varicella zoster virus
Herpes simplex virus
Influenza virus
Norovirus
HIV (AIDS)
Miscellaneous cell wall synthesis inhibitors
Complement system
B-cell development
MHC class I and MHC class II molecules
T-cell activation
B-cell activation, differentiation, and contraction
Cell-mediated immunity of CD4 cells
Cell-mediated immunity of natural killer and CD8 cells
Antibody classes
VDJ rearrangement
Somatic hypermutation and affinity maturation
Contracting the immune response and peripheral tolerance
B- and T-cell memory
Abscesses
X-linked agammaglobulinemia
Selective immunoglobulin A deficiency
DiGeorge syndrome
Hyper IgM syndrome
Leukocyte adhesion deficiency
Complement deficiency
Immunodeficiencies: T-cell and B-cell disorders: Pathology review
Immunodeficiencies: Phagocyte and complement dysfunction: Pathology review
Immunodeficiencies: Combined T-cell and B-cell disorders: Pathology review
Vitamin B12 deficiency
Folate (Vitamin B9) deficiency
Hemophilia
Von Willebrand disease
Disseminated intravascular coagulation
Protein C deficiency
Antiphospholipid syndrome
Protein S deficiency
Factor V Leiden
Non-hemolytic normocytic anemia: Pathology review
Intrinsic hemolytic normocytic anemia: Pathology review
Extrinsic hemolytic normocytic anemia: Pathology review
Macrocytic anemia: Pathology review
Coagulation disorders: Pathology review
Platelet disorders: Pathology review
Mixed platelet and coagulation disorders: Pathology review
Thrombosis syndromes (hypercoagulability): Pathology review
Anticoagulants: Heparin
Anticoagulants: Warfarin
Anticoagulants: Direct factor inhibitors
Antiplatelet medications
Neisseria gonorrhoeae
Haemophilus influenzae
Chlamydia pneumoniae
Viral structure and functions
Candida
Mechanisms of antibiotic resistance
Neuraminidase inhibitors
Neisseria meningitidis
Mycobacterium avium complex (NORD)
Chlamydia trachomatis
Treponema pallidum (Syphilis)
Human herpesvirus 8 (Kaposi sarcoma)
Epstein-Barr virus (Infectious mononucleosis)
Antituberculosis medications
Non-nucleoside reverse transcriptase inhibitors (NNRTIs)
Herpesvirus medications
Nucleoside reverse transcriptase inhibitors (NRTIs)
Vaccinations
Autoimmune hemolytic anemia
Anemia of chronic disease
Atherosclerosis and arteriosclerosis: Pathology review
Coronary artery disease: Pathology review
Peripheral artery disease: Pathology review
Valvular heart disease: Pathology review
Cardiomyopathies: Pathology review
Heart failure: Pathology review
Aortic dissections and aneurysms: Pathology review
Hypertension: Pathology review
Obstructive lung diseases: Pathology review
Apnea, hypoventilation and pulmonary hypertension: Pathology review
Restrictive lung diseases: Pathology review

Transcript

Watch video only

At the emergency department, a 70 year old male named Max is admitted because of high fever with chills, and hypotension. He complains of having urinary urgency, frequency and dysuria, or painful urination, for the last few days. A few hours after admission, he rapidly deteriorates and starts to bleed from venipuncture sites. Urine and blood cultures are ordered and are both positive for gram negative rods. Lab tests show low platelet count, and bleeding time, PT and PTT are prolonged, fibrinogen is decreased and d-dimers are elevated. Peripheral blood smear shows schistocytes. Now, there’s also an 18 year old female, named Sylvia, that came in with recurrent severe nose bleeds. She also complains of heavy menstrual periods. Family history reveals her father also suffered from bleeding diathesis. Lab tests show normal platelet count, prolonged bleeding time and PTT, and normal PT.

Both Max and Sylvia are suffering from a hemostasis disorder. Hemostasis disorders, also known as bleeding disorders, can be broadly divided into three groups. The first includes problems with primary hemostasis, which is the formation of the weak platelet plug, and so, they’re referred to as platelet disorders. Now, the second group includes problems with secondary hemostasis, which is making a strong fibrin clot through activation of the intrinsic, extrinsic and common coagulation pathways, and are also known as coagulation disorders. And the last group includes disorders that affect both primary and secondary hemostasis and are known as mixed platelet and coagulation disorders. Okay, in this video, we will focus on mixed platelet and coagulation disorders, that include disseminated intravascular coagulation, or DIC, and von Willebrand disease.

Alright, so let’s take a closer look at these disorders, starting with DIC, which is a massive overactivation of the coagulation system including both platelets and clotting factors. For your exams, it’s important to know that DIC can occur in response to serious conditions including gram negative bacterial sepsis, trauma, and obstetric complications such as abruptio placenta and retained dead fetus in utero, acute pancreatitis, malignancies such as adenocarcinomas and promyelocytic leukemia, nephrotic syndrome, snakebites, and transfusion reactions. Okay, whatever the cause, there is a release of a procoagulant that tips the scales in favor of clot formation. Procoagulants could be enzymes that help to proteolytically cleave and activate clotting factors or proteins like bacterial components such as lipopolysaccharide or tissue factor also known as thromboplastin. For your test, remember that the release of tissue factor from abruptio placenta into the maternal circulation, is, in fact, the most common cause of DIC in pregnancy. DIC leads to widespread clotting, which can block off small arteries leading to organ ischemia. These clots also act like jagged rocks in a river and damage the red blood cells floating by, causing microangiopathic hemolytic anemia. These damaged RBCs can be seen on a blood smear as schistocytes but sometimes they get destroyed completely. At the same time, excessive clot formation depletes platelets and clotting factors, which paradoxically, leads to increased bleeding.

Now, let’s move onto von Willebrand disease, the most common inherited bleeding disorder. It’s usually caused by autosomal dominant mutations of von Willebrand factor. These proteins normally serves as the glue between the platelet receptor Gp1b and the collagen underneath the endothelial cells. So, for the test remember that if there’s a problem with von Willebrand factor, it’s hard for platelets to adhere to collagen in damaged blood vessels, leading to impaired platelet function. Inherited von Willebrand disease is subclassified into type 1, which is a decrease in the quantity of von Willebrand factor, and type 2, which is a decrease in the function of von Willebrand factor. Meanwhile, von Willebrand factor also stabilize factor 8 of the intrinsic coagulation pathway. So without von Willebrand factor, there’s less functioning factor 8 around, leading to decreased activation of the coagulation cascade.

So mixed platelet and coagulation disorders affect both primary and secondary hemostasis, and as a result they can present with symptoms caused by dysfunctions in both pathways. Primary hemostatic, or platelet, problems usually present with petechiae, which are pinpoint superficial skin bleeds, anterior epistaxis, which are usually mild nosebleeds, immediate bleeding after surgical procedures, like tooth extraction, or bleeding from mucosal surfaces, like gingival, gastrointestinal, or vaginal bleeding. In contrast, secondary hemostatic, or coagulation, problems can present with large bruises after minor trauma, like bumping into a door. They also suffer from ecchymoses, which is discoloration caused by bleeding under the skin, deep tissue hematomas, hemarthrosis, which is bleeding inside the joint space, posterior epistaxis, which causes a severe nosebleed, GI bleeding, urinary bleeding, and persistent bleeding after surgical procedures.Now, a dangerous complication is intracerebral hemorrhage, or bleeding into the brain, which can cause a stroke or increased intracranial pressure.

Sources

  1. "Robbins Basic Pathology" Elsevier (2017)
  2. "Harrison's Principles of Internal Medicine, Twentieth Edition (Vol.1 & Vol.2)" McGraw-Hill Education / Medical (2018)
  3. "Diagnosis and Treatment of Benign Bleeding Disorders" Journal of the Advanced Practitioner in Oncology (2016)
  4. "Bleeding and Coagulopathies in Critical Care" New England Journal of Medicine (2014)
  5. "Disseminated intravascular coagulation" Nature Reviews Disease Primers (2016)
  6. "von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA)" Haemophilia (2008)
  7. "The diagnosis and management of von Willebrand disease: a United Kingdom Haemophilia Centre Doctors Organization guideline approved by the British Committee for Standards in Haematology" British Journal of Haematology (2014)